ARCH Venture Partners VII, L.P.
Insider CIK 1544444 · BLUE 10% owner · PZRX 10% owner · AGIO 10% owner · UBX 10% owner · RCPT 10% owner · MASS 10% owner · SYRS 10% owner · PULM 10% owner · TWST 10% owner · JUNO 10% owner · SAGE 10% owner · NMRA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NMRA Neumora Therapeutics, Inc. | P Buy | 2025-10-27 | 2025-10-29 | 1,915,700 | $2.61 | $5.00M | 6,046,907 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | J Other | 2023-12-08 | 2023-12-12 | 1,176,593 | — | $0 | 2,321,566 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | J Other | 2023-12-08 | 2023-12-12 | 703,061 | — | $0 | 1,387,228 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 6,895,021 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 6,576,400 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 1,144,973 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 684,167 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 2,124,143 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 684,167 | — | $0 | 684,167 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 1,144,973 | — | $0 | 1,144,973 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 6,895,021 | — | $0 | 12,205,379 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 6,576,400 | — | $0 | 11,886,758 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 2,124,143 | — | $0 | 2,124,143 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-19 | 2023-09-20 | 1,500,000 | $17.00 | $25.50M | 3,624,143 | SEC↗ |
| MASS 908 Devices Inc. | C Conversion deriv | 2020-12-22 | 2020-12-22 | 2,927,386 | — | $0 | 0 | SEC↗ |
| MASS 908 Devices Inc. | C Conversion deriv | 2020-12-22 | 2020-12-22 | 669,977 | — | $0 | 0 | SEC↗ |
| MASS 908 Devices Inc. | C Conversion deriv | 2020-12-22 | 2020-12-22 | 665,661 | — | $0 | 0 | SEC↗ |
| MASS 908 Devices Inc. | C Conversion deriv | 2020-12-22 | 2020-12-22 | 180,578 | — | $0 | 0 | SEC↗ |
| MASS 908 Devices Inc. | C Conversion deriv | 2020-12-22 | 2020-12-22 | 981,443 | — | $0 | 0 | SEC↗ |
| MASS 908 Devices Inc. | P Buy | 2020-12-22 | 2020-12-22 | 300,000 | $20.00 | $6.00M | 5,725,045 | SEC↗ |
| MASS 908 Devices Inc. | C Conversion | 2020-12-22 | 2020-12-22 | 5,425,045 | — | $0 | 5,425,045 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-07-17 | 2019-07-17 | 34,521 | $7.70 | $265.8K | 4,242,051 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-07-16 | 2019-07-17 | 25,779 | $7.81 | $201.3K | 4,276,572 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-07-15 | 2019-07-17 | 2,700 | $8.27 | $22.3K | 4,302,051 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-03-14 | 2019-03-14 | 43,000 | $8.15 | $350.4K | 4,305,051 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-03-13 | 2019-03-14 | 2,820 | $8.20 | $23.1K | 4,348,051 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-03-13 | 2019-03-14 | 81,591 | $7.89 | $643.8K | 4,350,871 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-03-12 | 2019-03-14 | 40,092 | $7.37 | $295.5K | 4,432,462 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-03-11 | 2019-03-11 | 44,878 | $6.49 | $291.3K | 4,472,554 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-03-08 | 2019-03-11 | 84,496 | $6.93 | $585.6K | 4,517,432 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-03-07 | 2019-03-11 | 35,209 | $6.87 | $241.9K | 4,601,928 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion deriv | 2018-11-02 | 2018-11-06 | 266,776 | — | $0 | 0 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion deriv | 2018-11-02 | 2018-11-06 | 1,182,645 | — | $0 | 0 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion deriv | 2018-11-02 | 2018-11-06 | 718,275 | — | $0 | 0 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion deriv | 2018-11-02 | 2018-11-06 | 224,726 | — | $0 | 0 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion deriv | 2018-11-02 | 2018-11-06 | 894,146 | — | $0 | 0 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion | 2018-11-02 | 2018-11-06 | 718,275 | — | $0 | 1,900,920 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion | 2018-11-02 | 2018-11-06 | 1,182,645 | — | $0 | 1,182,645 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion | 2018-11-02 | 2018-11-06 | 266,776 | — | $0 | 2,167,696 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion | 2018-11-02 | 2018-11-06 | 224,726 | — | $0 | 2,392,422 | SEC↗ |
| TWST Twist Bioscience Corp | P Buy | 2018-11-02 | 2018-11-06 | 15,000 | $14.00 | $210.0K | 2,407,422 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion | 2018-11-02 | 2018-11-06 | 894,146 | — | $0 | 894,146 | SEC↗ |
| TWST Twist Bioscience Corp | P Buy | 2018-11-02 | 2018-11-06 | 60,000 | $14.00 | $840.0K | 954,146 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 1,486,745 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 2,067,160 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 2,030,625 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 195,672 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 4,228,432 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 2,067,160 | — | $0 | 8,365,764 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 1,486,745 | — | $0 | 1,486,745 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 195,672 | — | $0 | 1,682,417 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 4,228,432 | — | $0 | 6,298,604 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 2,030,625 | — | $0 | 2,070,172 | SEC↗ |
| PULM Pulmatrix, Inc. | P Buy deriv | 2018-04-03 | 2018-04-05 | 1,150,000 | — | $0 | 1,150,000 | SEC↗ |
| PULM Pulmatrix, Inc. | P Buy deriv | 2018-04-03 | 2018-04-05 | 1,150,000 | — | $0 | 1,150,000 | SEC↗ |
| PULM Pulmatrix, Inc. | P Buy | 2018-04-03 | 2018-04-05 | 1,150,000 | — | $0 | 3,436,456 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 1,589,269 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 7,500,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 1,000,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 5,000,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 2,000,000 | — | $0 | 3,813,332 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 1,333,333 | — | $0 | 1,813,332 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 266,666 | — | $0 | 479,999 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2016-07-06 | 2016-07-07 | 400,000 | $12.50 | $5.00M | 4,637,137 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 423,805 | — | $0 | 4,237,137 | SEC↗ |
| PZRX PHASERX, INC. | A Award deriv | 2016-05-23 | 2016-05-25 | 9,385 | — | $0 | 9,385 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-25 | 195,156 | $0.01 | $2.0K | 1,854,222 | SEC↗ |
| PZRX PHASERX, INC. | P Buy | 2016-05-23 | 2016-05-25 | 1,000,000 | $5.00 | $5.00M | 2,854,222 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-25 | 484,903 | $0.01 | $4.8K | 2,049,378 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | J Other | 2016-03-15 | 2016-03-17 | 1,000,000 | — | $0 | 10,552,390 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-06-18 | 2015-06-22 | 1,062,345 | — | $0 | 2,124,699 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2015-06-16 | 2015-06-17 | 17,710 | — | $0 | 17,710 | SEC↗ |
| PULM Pulmatrix, Inc. | P Buy | 2015-06-16 | 2015-06-17 | 72,750 | $6.88 | $500.5K | 2,286,456 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2015-06-15 | 2015-06-17 | 797,506 | — | $0 | 797,506 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2015-06-15 | 2015-06-25 | 797,506 | — | $0 | 797,506 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award | 2015-06-15 | 2015-06-17 | 2,213,706 | — | $0 | 2,213,706 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | J Other | 2015-02-19 | 2015-02-23 | 386,074 | — | $0 | 3,088,590 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-01-14 | 2015-01-16 | 1,062,345 | — | $0 | 3,187,044 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2014-12-23 | 457,875 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2014-12-23 | 3,747,500 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2014-12-23 | 6,250,000 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2014-12-23 | 6,250,000 | — | $0 | 7,347,015 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2014-12-23 | 457,875 | — | $0 | 11,552,390 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2014-12-23 | 3,747,500 | — | $0 | 11,094,515 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion deriv | 2014-07-23 | 2014-07-23 | 7,500,000 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion deriv | 2014-07-23 | 2014-07-23 | 5,000,000 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion deriv | 2014-07-23 | 2014-07-23 | 885,583 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion | 2014-07-23 | 2014-07-23 | 281,137 | — | $0 | 4,249,389 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion | 2014-07-23 | 2014-07-23 | 2,380,951 | — | $0 | 3,968,252 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion | 2014-07-23 | 2014-07-23 | 1,587,301 | — | $0 | 1,587,301 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | J Other | 2014-06-23 | 2014-06-25 | 386,074 | — | $0 | 3,474,664 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2014-05-14 | 2014-05-15 | 488 | $28.39 | $13.9K | 127,116 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2014-05-14 | 2014-05-15 | 7,907 | $28.39 | $224.5K | 2,058,634 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2014-05-13 | 2014-05-15 | 616 | $28.72 | $17.7K | 129,139 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2014-05-13 | 2014-05-15 | 1,535 | $30.44 | $46.7K | 127,604 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2014-05-13 | 2014-05-15 | 10,013 | $28.72 | $287.6K | 2,091,363 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2014-05-13 | 2014-05-15 | 24,822 | $30.44 | $755.6K | 2,066,541 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | C Conversion deriv | 2013-07-29 | 2013-07-31 | 617,031 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | C Conversion deriv | 2013-07-29 | 2013-07-31 | 10,000,000 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | C Conversion | 2013-07-29 | 2013-07-31 | 3,860,738 | — | $0 | 3,860,738 | SEC↗ |
| BLUE bluebird bio, Inc. | C Conversion deriv | 2013-06-24 | 2013-06-26 | 19,971,242 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | C Conversion deriv | 2013-06-24 | 2013-06-26 | 14,047,762 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | C Conversion | 2013-06-24 | 2013-06-26 | 1,793,588 | — | $0 | 1,793,588 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-05-14 | 973,165 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-05-14 | 7,667,124 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-05-14 | 5,102,426 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-05-14 | 129,755 | — | $0 | 129,755 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-05-14 | 1,022,283 | — | $0 | 1,136,568 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-05-14 | 680,323 | — | $0 | 1,816,891 | SEC↗ |
| RCPT Receptos, Inc. | P Buy | 2013-05-14 | 2013-05-14 | 284,485 | $14.00 | $3.98M | 2,101,376 | SEC↗ |